Tandem Capital Management Corp Acadia Pharmaceuticals Inc Transaction History

Tandem Capital Management Corp

  • $167 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$25.02 - $54.99 $196,607 - $432,111
-7,858 Closed
0 $0
Q4 2020

Feb 01, 2021
BUY
$41.04 - $56.79 $111,628 - $154,468
2,720 Added 52.94%
7,858 $420,000
Q3 2020

Nov 03, 2020
BUY
$36.42 - $57.0 $187,125 - $292,866
5,138 New
5,138 $212,000

Others Institutions Holding ACAD

# of Institutions
288
Shares Held
161M
Call Options Held
723K
Put Options Held
257K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.49B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Tandem Capital Management Corp Portfolio

Follow Tandem Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tandem Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Tandem Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email